ANAHEIM, Calif.—Daily dosing of sildenafil (Viagra) may offer both penile vascular and cardiovascular health benefits in type 2 diabetic men with erectile dysfunction (ED), according to a study at Johns Hopkins School of Medicine in Baltimore.

VIENNA—Erectile dysfunction (ED) may be a common adverse effect of thalidomide used to treat hematologic diseases, according to a study presented here at the 12th Congress of the European Hematology Association.

ANAHEIM, Calif.—Erectile dysfunction (ED) may predict future coronary heart disease (CHD).

QUEBEC CITY—A Canadian study of men with erectile dysfunction (ED) following prostate cancer therapy showed that those who received radiation therapy alone had greater success with ED treatment than men treated with radical prostatectomy alone or in combination with radiation.

BERLIN—Two recent French studies have characterized the effect of prostate brachytherapy on erectile and ejaculatory function.

It’s increasingly clear that erectile dysfunction (ED) is strongly linked to a range of underlying ailments including systemic vascular disease, diabetes, and obesity. These disorders, in turn, are associated with diet, exercise, and other lifestyle and emotional factors.

A study of men in a rural community in Brazil revealed an extremely low prevalence of erectile dysfunction (ED).

Vascular disease may explain the previously established link be-tween smoking and erectile dysfunction (ED), a Finnish study suggests. Additionally, ED may be a silent vascular disease in ex-smokers.

EARLY USE of phosphodiesterase inhibitors (PDEIs) following brachytherapy is associated with improved erectile function compared with late use of the drugs.

THE FIRST human study using gene transfer to treat erectile dysfunction (ED) shows promising results, according to researchers.